[go: up one dir, main page]

AU2001260727A1 - Solid dispersion system of pranlukast with improved dissolution, and the preparing method thereof - Google Patents

Solid dispersion system of pranlukast with improved dissolution, and the preparing method thereof

Info

Publication number
AU2001260727A1
AU2001260727A1 AU2001260727A AU6072701A AU2001260727A1 AU 2001260727 A1 AU2001260727 A1 AU 2001260727A1 AU 2001260727 A AU2001260727 A AU 2001260727A AU 6072701 A AU6072701 A AU 6072701A AU 2001260727 A1 AU2001260727 A1 AU 2001260727A1
Authority
AU
Australia
Prior art keywords
pranlukast
solid dispersion
dispersion system
preparing method
improved dissolution
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001260727A
Inventor
Sang Deuk Lee
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of AU2001260727A1 publication Critical patent/AU2001260727A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Otolaryngology (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
AU2001260727A 2000-05-20 2001-05-17 Solid dispersion system of pranlukast with improved dissolution, and the preparing method thereof Abandoned AU2001260727A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
KR0027237 2000-05-20
KR10-2000-0027237A KR100381834B1 (en) 2000-05-20 2000-05-20 Solid dispersion system of pranlukast with improved dissolution, and the method thereof
PCT/KR2001/000804 WO2001089574A1 (en) 2000-05-20 2001-05-17 Solid dispersion system of pranlukast with improved dissolution, and the preparing method thereof

Publications (1)

Publication Number Publication Date
AU2001260727A1 true AU2001260727A1 (en) 2001-12-03

Family

ID=36794425

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001260727A Abandoned AU2001260727A1 (en) 2000-05-20 2001-05-17 Solid dispersion system of pranlukast with improved dissolution, and the preparing method thereof

Country Status (9)

Country Link
US (1) US20030077322A1 (en)
EP (1) EP1283725B1 (en)
JP (1) JP3967924B2 (en)
KR (1) KR100381834B1 (en)
CN (1) CN1210065C (en)
AU (1) AU2001260727A1 (en)
CA (1) CA2405459A1 (en)
DE (1) DE60121574T2 (en)
WO (1) WO2001089574A1 (en)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100531612B1 (en) * 2003-08-12 2005-11-28 경동제약 주식회사 PREPARING METHOD FOR CONTROLLED RELEASED TYPE TABLET TAMSULOSIN HCl AND THE TABLET THEREOF
DE10350528A1 (en) * 2003-10-29 2005-06-09 Boehringer Ingelheim Pharma Gmbh & Co. Kg Drug formulation containing an LTB4 antagonist, as well as processes for their preparation and their use
EP1686965A2 (en) * 2003-11-18 2006-08-09 Boehringer Ingelheim International GmbH Solid pharmaceutical preparation form
WO2005105039A1 (en) * 2004-05-04 2005-11-10 Boehringer Ingelheim International Gmbh Solid pharmaceutical form comprising an ltb4 antagonist
JP2006206612A (en) * 2004-05-27 2006-08-10 Ono Pharmaceut Co Ltd Composition for solid preparation
JP4742679B2 (en) * 2004-05-27 2011-08-10 小野薬品工業株式会社 Composition for solid preparation
JP2007223903A (en) * 2004-07-09 2007-09-06 Takeda Chem Ind Ltd Novel solid dispersion and its manufacturing method
CN102847155B (en) * 2004-07-14 2014-04-16 炎症研究中心有限公司 Method for inhibiting tumor metastasis
KR101086254B1 (en) * 2004-11-04 2011-11-24 에스케이케미칼주식회사 Franlukast solid dispersion composition with improved bioavailability and method for preparing the solid dispersion
KR101233235B1 (en) * 2005-08-26 2013-02-15 에스케이케미칼주식회사 Pharmaceutical composition of pranlukast solid-dispersion with improved early dissolution rate and the method of preparing the composition
JP4870402B2 (en) * 2005-09-01 2012-02-08 小林化工株式会社 Method for producing pranlukast hydrate-containing tablets
KR100715355B1 (en) 2005-09-30 2007-05-07 주식회사유한양행 Spray-Dried Granules Containing Franlukast and Methods for Making the Same
KR100981751B1 (en) * 2005-10-28 2010-09-10 주식회사유한양행 Granules containing Franlukast and preparation method thereof
KR100981750B1 (en) 2005-10-28 2010-09-10 주식회사유한양행 Spray-dried granules and preparation method thereof
EP2659882A4 (en) * 2010-12-27 2014-11-12 Tomita Pharma DISAGGREGATION TYPE NUCLEAR PARTICLE FOR PHARMACEUTICAL FORMULATION
CN102178647B (en) * 2011-04-28 2012-09-12 重庆圣华曦药物研究开发有限公司 Pranlukast injection preparation
KR101378951B1 (en) * 2011-07-29 2014-03-31 재단법인 유타 인하 디디에스 및 신의료기술개발 공동연구소 Oral formulation comprising megestrol acetate powder with enhanced bioavailability, and method for preparing the same
CN103751108A (en) * 2013-12-31 2014-04-30 北京万全德众医药生物技术有限公司 Pranlukast solid dispersion and preparation method thereof
WO2016198983A1 (en) 2015-06-09 2016-12-15 Bend Research Inc. Formulations to achieve rapid dissolution of drug from spray-dried dispersions in capsules
KR20250052834A (en) 2023-10-12 2025-04-21 주식회사 다산제약 Pharmaceutical composition with improved bioavailability of pranlukast and manufacturing method thereof

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0834314T3 (en) * 1995-06-12 2003-02-24 Ono Pharmaceutical Co Granules containing pranlukast, method of making the granules, and method of reducing pranlukast's adhesiveness
US6503537B2 (en) * 1997-03-20 2003-01-07 Schering Corporation Preparation of powder agglomerates
TW546151B (en) * 1997-07-23 2003-08-11 Senju Pharma Co Aqueous liquid pharmaceutical composition containing as main component benzopyran derivative
US6224907B1 (en) * 1998-03-06 2001-05-01 Alza Corporation Anti-asthma therapy
US6267985B1 (en) * 1999-06-30 2001-07-31 Lipocine Inc. Clear oil-containing pharmaceutical compositions
US6248363B1 (en) * 1999-11-23 2001-06-19 Lipocine, Inc. Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
US6383471B1 (en) * 1999-04-06 2002-05-07 Lipocine, Inc. Compositions and methods for improved delivery of ionizable hydrophobic therapeutic agents

Also Published As

Publication number Publication date
EP1283725B1 (en) 2006-07-19
JP3967924B2 (en) 2007-08-29
CN1210065C (en) 2005-07-13
DE60121574T2 (en) 2007-06-21
KR100381834B1 (en) 2003-04-26
CN1430521A (en) 2003-07-16
US20030077322A1 (en) 2003-04-24
JP2003534296A (en) 2003-11-18
EP1283725A1 (en) 2003-02-19
KR20010106006A (en) 2001-11-29
CA2405459A1 (en) 2001-11-29
WO2001089574A1 (en) 2001-11-29
DE60121574D1 (en) 2006-08-31
EP1283725A4 (en) 2003-06-25

Similar Documents

Publication Publication Date Title
AU2001260727A1 (en) Solid dispersion system of pranlukast with improved dissolution, and the preparing method thereof
AU2513400A (en) Authentication system and process
AU2002213273A1 (en) Stenoprophiluric matrices, and methods of making and using the same
AU6629400A (en) Authentication system and method
AU3614901A (en) Polyorganosilsesquioxane and process for preparing the same
ZA200004485B (en) Sustained release microparticle and method for preparing the same.
MXPA01008882A (en) Method and system for the discovery of cookies and other client information.
AU5194999A (en) Benzothiepin derivatives, process for the preparation of the same and uses thereof
AU4137601A (en) Methods, systems, and apparatuses for secure interactions
AU2001241068A1 (en) Indole derivatives, process for preparation of the same and use thereof
AU2856499A (en) Novel substances kf-1040t4a, kf-1040t4b, kf-1040t5a and kf-1040t5b and process for producing the same
AU2001278720A1 (en) Method of preparing publication, electronic publication using the method and displaying method therefor and network system
AU2002250858A1 (en) Capsule-in-capsule system and method for the production thereof
AU2001270292A1 (en) Structural biocomposite materials, systems, and methods
AU5107500A (en) Oxime derivatives, process for the preparation thereof and pesticides
AU3425700A (en) Non-ribosomal peptide synthetases, method for producing same and the use thereof
AU2002213227A1 (en) Generalizer system and method
AU2001260774A1 (en) Bio-support and preparing method of the same
AU2001296604A1 (en) Simd system and method
MXPA03003286A (en) Pigment dispersion and method of preparing the same.
AU2002233239A1 (en) Microparticles with an improved release profile and method for the production thereof
AU7446900A (en) Thioalkylamine derivatives and process for the preparation thereof
AU6866500A (en) Chromone derivatives, process for the preparation of the same and uses thereof
AU2001261193A1 (en) Integrated security system and method
AU2002227966A1 (en) Coniosetin and derivatives thereof, method for producing the same and use thereof

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase
TH Corrigenda

Free format text: IN VOL 16, NO 12, PAGE(S) 2688-2711 UNDER THE HEADING APPLICATIONS LAPSED, REFUSED OR WITHDRAWN PLEASE DELETE ALL REFERENCE TO APPLICATION NO. 60727/01, 74288/01 AND 74687/01